nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCC1—Mitoxantrone—multiple sclerosis	0.14	0.153	CbGbCtD
Sulfinpyrazone—ABCC3—Methotrexate—multiple sclerosis	0.0953	0.104	CbGbCtD
Sulfinpyrazone—ABCC4—Methotrexate—multiple sclerosis	0.0728	0.0793	CbGbCtD
Sulfinpyrazone—ABCC1—Methotrexate—multiple sclerosis	0.0585	0.0637	CbGbCtD
Sulfinpyrazone—ABCC2—Dexamethasone—multiple sclerosis	0.0539	0.0587	CbGbCtD
Sulfinpyrazone—ABCB1—Methylprednisolone—multiple sclerosis	0.0465	0.0506	CbGbCtD
Sulfinpyrazone—ABCC2—Methotrexate—multiple sclerosis	0.0433	0.0472	CbGbCtD
Sulfinpyrazone—CYP3A4—Fingolimod—multiple sclerosis	0.0432	0.047	CbGbCtD
Sulfinpyrazone—CYP2B6—Dexamethasone—multiple sclerosis	0.0343	0.0373	CbGbCtD
Sulfinpyrazone—ABCB1—Mitoxantrone—multiple sclerosis	0.0339	0.0369	CbGbCtD
Sulfinpyrazone—ABCB1—Betamethasone—multiple sclerosis	0.0302	0.0329	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisolone—multiple sclerosis	0.0298	0.0324	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisone—multiple sclerosis	0.0282	0.0306	CbGbCtD
Sulfinpyrazone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0278	0.0303	CbGbCtD
Sulfinpyrazone—CYP2C8—Dexamethasone—multiple sclerosis	0.026	0.0283	CbGbCtD
Sulfinpyrazone—CYP3A4—Triamcinolone—multiple sclerosis	0.0211	0.023	CbGbCtD
Sulfinpyrazone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0203	0.0221	CbGbCtD
Sulfinpyrazone—CYP2C9—Dexamethasone—multiple sclerosis	0.0181	0.0197	CbGbCtD
Sulfinpyrazone—CYP3A4—Betamethasone—multiple sclerosis	0.0181	0.0197	CbGbCtD
Sulfinpyrazone—CYP3A4—Prednisolone—multiple sclerosis	0.0179	0.0194	CbGbCtD
Sulfinpyrazone—ABCB1—Dexamethasone—multiple sclerosis	0.0176	0.0191	CbGbCtD
Sulfinpyrazone—CYP3A4—Prednisone—multiple sclerosis	0.0169	0.0184	CbGbCtD
Sulfinpyrazone—ABCB1—Methotrexate—multiple sclerosis	0.0141	0.0154	CbGbCtD
Sulfinpyrazone—CYP3A4—Dexamethasone—multiple sclerosis	0.0105	0.0115	CbGbCtD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000263	0.00325	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000263	0.00325	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000261	0.00323	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000244	0.00301	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000239	0.00295	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000236	0.00291	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000236	0.00291	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000234	0.00288	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000234	0.00288	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000231	0.00284	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000231	0.00284	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000228	0.00281	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000226	0.00278	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000221	0.00272	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000215	0.00265	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00021	0.00259	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00021	0.00259	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000205	0.00253	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000202	0.00249	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—ALB—multiple sclerosis	0.000194	0.0024	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00019	0.00235	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00019	0.00235	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000188	0.00232	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000188	0.00232	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000185	0.00228	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—SRM—multiple sclerosis	0.00018	0.00222	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000178	0.00219	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PLEK—multiple sclerosis	0.000177	0.00218	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000174	0.00215	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000173	0.00213	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00017	0.0021	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000168	0.00207	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000165	0.00204	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000164	0.00203	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000164	0.00203	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000164	0.00202	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000163	0.00201	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000158	0.00194	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000155	0.00192	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000154	0.0019	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000153	0.00189	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00015	0.00185	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000144	0.00178	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000142	0.00175	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—GPC5—multiple sclerosis	0.000138	0.00171	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000137	0.00169	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000136	0.00167	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000135	0.00166	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—SRM—multiple sclerosis	0.000133	0.00164	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000129	0.00159	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000129	0.00159	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000128	0.00158	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000127	0.00157	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CYP27B1—multiple sclerosis	0.000127	0.00156	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CYP24A1—multiple sclerosis	0.000127	0.00156	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000125	0.00155	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000125	0.00155	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—SELE—multiple sclerosis	0.000124	0.00154	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000124	0.00153	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000124	0.00153	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000123	0.00152	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	0.000123	0.00152	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000122	0.00151	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000121	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000121	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.000121	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.000121	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000119	0.00147	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	0.000117	0.00145	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000117	0.00144	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000117	0.00144	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GPC5—multiple sclerosis	0.000116	0.00143	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	0.000115	0.00142	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000114	0.0014	CbGpPWpGaD
Sulfinpyrazone—ABCC5—NRF2 pathway—TGFB1—multiple sclerosis	0.00011	0.00135	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	0.000108	0.00134	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	0.000108	0.00133	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000107	0.00132	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	0.000106	0.00131	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—SRM—multiple sclerosis	0.000104	0.00128	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000102	0.00126	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000101	0.00124	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.94e-05	0.00123	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.9e-05	0.00122	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	9.72e-05	0.0012	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—RRM1—multiple sclerosis	9.6e-05	0.00119	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CYP27B1—multiple sclerosis	9.34e-05	0.00115	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CYP24A1—multiple sclerosis	9.34e-05	0.00115	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.13e-05	0.00113	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.01e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—RPL5—multiple sclerosis	9e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—ITGA4—multiple sclerosis	8.99e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.98e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.97e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.97e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IFNB1—multiple sclerosis	8.93e-05	0.0011	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.9e-05	0.0011	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	8.62e-05	0.00106	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SLC11A1—multiple sclerosis	8.62e-05	0.00106	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GPC5—multiple sclerosis	8.54e-05	0.00105	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	8.08e-05	0.000997	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.06e-05	0.000994	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8e-05	0.000987	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—GPC5—multiple sclerosis	7.99e-05	0.000986	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	7.96e-05	0.000983	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.77e-05	0.000959	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	7.59e-05	0.000937	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CYP27B1—multiple sclerosis	7.32e-05	0.000903	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CYP24A1—multiple sclerosis	7.32e-05	0.000903	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.3e-05	0.000901	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.3e-05	0.000901	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	7.23e-05	0.000892	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.15e-05	0.000883	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	7.1e-05	0.000876	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—RRM1—multiple sclerosis	7.08e-05	0.000874	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.99e-05	0.000862	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CD28—multiple sclerosis	6.88e-05	0.000849	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—SRM—multiple sclerosis	6.7e-05	0.000827	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GPC5—multiple sclerosis	6.69e-05	0.000826	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.55e-05	0.000809	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	6.4e-05	0.00079	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	6.33e-05	0.000782	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	6.31e-05	0.000779	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.24e-05	0.00077	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.21e-05	0.000766	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL2RA—multiple sclerosis	6.14e-05	0.000758	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.06e-05	0.000748	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—SRM—multiple sclerosis	5.67e-05	0.0007	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.55e-05	0.000685	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—RRM1—multiple sclerosis	5.55e-05	0.000685	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—BCHE—multiple sclerosis	5.52e-05	0.000681	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.49e-05	0.000678	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.45e-05	0.000673	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.35e-05	0.00066	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.34e-05	0.000659	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.31e-05	0.000656	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.26e-05	0.000649	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—RPL5—multiple sclerosis	5.2e-05	0.000641	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SLC11A1—multiple sclerosis	4.98e-05	0.000614	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—SRM—multiple sclerosis	4.94e-05	0.00061	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.92e-05	0.000607	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CD86—multiple sclerosis	4.91e-05	0.000606	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.79e-05	0.000591	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.72e-05	0.000583	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.72e-05	0.000583	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.72e-05	0.000582	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SRM—multiple sclerosis	4.62e-05	0.00057	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.6e-05	0.000567	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—ALB—multiple sclerosis	4.44e-05	0.000548	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CCR5—multiple sclerosis	4.35e-05	0.000537	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.32e-05	0.000533	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.3e-05	0.000531	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.3e-05	0.000531	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.28e-05	0.000528	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HLA-A—multiple sclerosis	4.24e-05	0.000524	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.23e-05	0.000523	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.09e-05	0.000505	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—BCHE—multiple sclerosis	4.07e-05	0.000502	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4e-05	0.000493	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4e-05	0.000493	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD28—multiple sclerosis	3.98e-05	0.000491	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—APOE—multiple sclerosis	3.96e-05	0.000489	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.91e-05	0.000482	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.85e-05	0.000475	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.7e-05	0.000456	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.66e-05	0.000451	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL2—multiple sclerosis	3.6e-05	0.000445	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CD80—multiple sclerosis	3.58e-05	0.000442	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.58e-05	0.000442	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.48e-05	0.00043	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.48e-05	0.00043	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.37e-05	0.000416	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—APOE—multiple sclerosis	3.32e-05	0.000409	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.25e-05	0.000401	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.25e-05	0.000401	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.24e-05	0.0004	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.2e-05	0.000396	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—BCHE—multiple sclerosis	3.19e-05	0.000393	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GPC5—multiple sclerosis	3.18e-05	0.000393	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.18e-05	0.000392	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.04e-05	0.000376	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.03e-05	0.000374	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TYK2—multiple sclerosis	3.02e-05	0.000373	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.98e-05	0.000367	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—POMC—multiple sclerosis	2.85e-05	0.000352	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD86—multiple sclerosis	2.84e-05	0.00035	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.82e-05	0.000348	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TGFB1—multiple sclerosis	2.81e-05	0.000347	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—MAPK1—multiple sclerosis	2.76e-05	0.00034	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CD4—multiple sclerosis	2.73e-05	0.000337	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.64e-05	0.000326	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ALB—multiple sclerosis	2.6e-05	0.000321	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CCR5—multiple sclerosis	2.52e-05	0.00031	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.47e-05	0.000304	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HLA-A—multiple sclerosis	2.45e-05	0.000303	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—APOE—multiple sclerosis	2.45e-05	0.000302	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.43e-05	0.0003	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.43e-05	0.0003	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.38e-05	0.000294	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.35e-05	0.00029	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—APOE—multiple sclerosis	2.29e-05	0.000282	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.27e-05	0.00028	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.15e-05	0.000265	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.15e-05	0.000265	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—STAT3—multiple sclerosis	2.12e-05	0.000261	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—POMC—multiple sclerosis	2.1e-05	0.000259	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD80—multiple sclerosis	2.07e-05	0.000255	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.05e-05	0.000254	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.02e-05	0.000249	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MYC—multiple sclerosis	1.97e-05	0.000243	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TGFB1—multiple sclerosis	1.96e-05	0.000242	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.96e-05	0.000242	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MAPK1—multiple sclerosis	1.92e-05	0.000238	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—APOE—multiple sclerosis	1.92e-05	0.000237	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ALB—multiple sclerosis	1.92e-05	0.000236	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.91e-05	0.000236	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.84e-05	0.000227	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TYK2—multiple sclerosis	1.75e-05	0.000216	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000215	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—POMC—multiple sclerosis	1.65e-05	0.000203	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.64e-05	0.000203	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000201	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD4—multiple sclerosis	1.58e-05	0.000195	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.52e-05	0.000188	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.52e-05	0.000187	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ALB—multiple sclerosis	1.5e-05	0.000185	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.5e-05	0.000185	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IL6—multiple sclerosis	1.48e-05	0.000183	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000175	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—APOE—multiple sclerosis	1.24e-05	0.000153	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—multiple sclerosis	1.22e-05	0.000151	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—multiple sclerosis	1.14e-05	0.00014	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TGFB1—multiple sclerosis	1.13e-05	0.00014	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MAPK1—multiple sclerosis	1.11e-05	0.000137	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—POMC—multiple sclerosis	1.06e-05	0.000131	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000129	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ALB—multiple sclerosis	9.68e-06	0.000119	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.34e-06	0.000115	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—APOE—multiple sclerosis	9.12e-06	0.000113	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—POMC—multiple sclerosis	8.99e-06	0.000111	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6—multiple sclerosis	8.54e-06	0.000105	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—APOE—multiple sclerosis	8.52e-06	0.000105	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ALB—multiple sclerosis	8.2e-06	0.000101	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—POMC—multiple sclerosis	7.83e-06	9.67e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—POMC—multiple sclerosis	7.32e-06	9.03e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALB—multiple sclerosis	7.14e-06	8.81e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALB—multiple sclerosis	6.67e-06	8.23e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—APOE—multiple sclerosis	5.62e-06	6.93e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.83e-06	5.96e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALB—multiple sclerosis	4.4e-06	5.43e-05	CbGpPWpGaD
